Medeprase Mimex Private Limited
Founded in 2022 and headquartered in Maharashtra, India.
2022 | Thane, Maharashtra (India) | Active
Medeprase Mimex Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Medeprase Mimex
Medeprase Mimex Private Limited (MMPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 July 2022 (Two years and eight months 18 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shadab Khan and Aaliya Khan serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33100MH2022PTC386654
- Company No.
386654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2022
- Date of AGM
24 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Medeprase Mimex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shadab Khan  | Director | 13-Jul-2022 | Current |
| Aaliya Khan | Director | 13-Jul-2022 | Current |
Financial Performance of Medeprase Mimex.
Enhance accessibility to Medeprase Mimex's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medeprase Mimex?
Unlock access to Medeprase Mimex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medeprase Mimex?
Unlock and access historical data on people associated with Medeprase Mimex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medeprase Mimex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medeprase Mimex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Medeprase Mimex
Recent activity within the organization
- Annual General Meeting
Medeprase Mimex Private Limited last Annual general meeting of members was held on 24 Oct 2023 as per latest MCA records.
- Balance Sheet
Medeprase Mimex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Shadab Sadruddin Khan was appointed as a Director was appointed as a Director on 13 Jul 2022 & has been associated with this company since 2 years 8 months .
- Director Appointment
Aaliya Mohd Khalil Khan was appointed as a Director was appointed as a Director on 13 Jul 2022 & has been associated with this company since 2 years 8 months .
- Company Incorporation
Medeprase Mimex Private Limited was registered on 13 Jul 2022 with Roc Mumbai & aged 2 years 8 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Medeprase Mimex Private Limited?
Medeprase Mimex Private Limited was incorporated on 13 Jul 2022.
What is authorized share capital and paid-up capital of Medeprase Mimex Private Limited?
The authorized share capital of Medeprase Mimex Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Medeprase Mimex Private Limited?
Currently 2 directors are associated with Medeprase Mimex Private Limited.
- Shadab Sadruddin Khan
- Aaliya Mohd Khalil Khan
What is the registered address of Medeprase Mimex Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Medeprase Mimex Private Limited is Sh No 1/A Rassaz Greens Nr Seven Eleven High School Ramdev Park Crossing Mira Rd India, Thane, Maharashtra, 401107.
What is the corporate identification number (CIN) and company number of Medeprase Mimex Private Limited?
The corporate identification number (CIN) of Medeprase Mimex Private Limited is U33100MH2022PTC386654 and the company number is 386654 as per Ministry of Corporate Affairs (MCA).
When was the last Balance Sheet of Medeprase Mimex Private Limited filed with the ROC?
The most recent Balance Sheet for Medeprase Mimex Private Limited was filed with the ROC on 31 Mar 2023.